Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05772052

Abnormal Eating and Taste Perception in Subjects With Obesity

The identification of safe and effective strategies for weight loss and long-term maintenance is critical to reduce the alarming prevalence of obesity worldwide and mitigate obesity-associated health risks. Specifically, Binge Eating (BE) and Food Addiction (FA) behaviors are well known causes of failed weight loss and weight regain. The definitions of their clinical phenotypes are currently evolving. Recent evidence suggests that food choices, behavior and reward may be driven also by taste perception.

The hypothesis of this study is that subjects with dysfunctional eating behavior have different taste thresholds compared to obese subjects without eating disorders, and that this characteristic influences food choice and eating behavior. Identifying a difference in the taste thresholds between obese with and without eating disorder will allow us to understand why certain individuals over-consume or binge on densely caloric foods and to give them a tailored dietary treatment so as to maintain weight loss for a long time.

The Binge eating and Food Addiction is assessed using Binge Eating Scale and Yale Food Addiction Scale 2.0. Subjects with obesity recruited are divided in 4 groups: without eating disorder, with food addiction (FA), with binge eating (BE) and with FA + BE. In these groups sweet and salty taste will be measured with the 3-Alternative-Forced-Choice method.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Istituto Auxologico Italiano

Milan, 20145, Italy

Location status: Recruiting

Location contact

Luisa Gilardini, MD

CONTACT

[email protected]

0261911 ext. 2561

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI>30 kg/m2 and <45 kg/m2

Exclusion criteria

  • uncooperative patients
  • heavy smokers
  • pregnancy or recent (in the last 6 months) childbirth
  • thyroid disorders
  • presence of endocrine abnormalities associated with obesity
  • current or recent oral, nasal or sinus infections
  • major psychiatric disorder even in pharmacological compensation
  • patients who had undergone bariatric surgery

Treatment and study plan

Primary outcomes

  1. sweet taste recognition threshold

    Time frame: baseline

    The sweet taste recognition threshold is assessed in subjects without eating disorders, with FA,with BE and FA+ BE

  2. salt taste recognition threshold

    Time frame: baseline

    The salt taste recognition threshold is assessed in subjects without eating disorders, with FA,with BE and FA+ BE

Secondary outcomes

  1. prevalence of binge eating (BE)

    Time frame: baseline

    percentage of subjects recruited with BE

  2. prevalence of Food Addiction (FA)

    Time frame: baseline

    percentage of subjects recruited with FA

  3. prevalence of Food Addiction (FA) + Binge Eating (BE)

    Time frame: baseline

    percentage of subjects recruited with FA+BE

Study contacts

Contact information is provided by the study sponsor or research team.

Luisa Gilardini, MF

CONTACT

[email protected]

+0261911 ext. 2561

Sponsors and collaborators

Lead sponsor

Istituto Auxologico Italiano

Other

Registry information

Official study title

Food Addiction, Binge Eating Disorder and Taste Perception in Subjects With Obesity

Acronym: TASTEOB

Important dates

Study start
2020
Primary completion
2026
Study completion
2026
First posted
Mar 16, 2023
Registry last updated
Oct 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.